Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline
SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, today announced […]
Invitae Launches its First CE-IVD Cancer Testing Kits In Europe
Invitae (NYSE: NVTA), a leading medical genetics company, today announced the availability of FusionPlex Dx® and LiquidPlex […]
Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform
Curve Therapeutics (Curve), a private biotechnology company pioneering a potentially game-changing, functional drug discovery platform, today […]
Aelis Farma Announces the Success of its Initial Public Offering and Raises Approximately €25 Million on Euronext Paris
Aelis Farma, a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases […]
A Study With Over 2,000 Cancers Missed by Screening Shows That Transpara AI Can Effectively Help Detect Breast Cancer Earlier
ScreenPoint Medical‘s Transpara AI decision support system can help radiologists to identify potential breast cancers […]
OxDX Raises £2.6M Pre-seed Funding to Develop AI Powered Rapid Diagnostic Technology
OxDX, a University of Oxford spin out building instant pathogen tests using super-resolution microscopy and […]
Adcentrx and AvantGen Enter a New Partnership with a Three-year, Multi-target Collaboration to Discover Antibodies for Novel Antibody-drug Conjugates
Adcentrx Therapeutics (“Adcentrx”), a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate (“ADC”) […]
AffaMed Therapeutics Announces IND Clearance by US FDA for AM712 - a Novel Bispecific Biologic for the Treatment of Retinal Vascular Diseases
AffaMed Therapeutics (“AffaMed”), a global clinical stage biotechnology company dedicated to developing and commercializing transformative […]
Bio-Rad Introduces Anti-Daratumumab Antibodies
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and […]
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Pfizer Inc. (NYSE: PFE), today announced positive top-line results […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more